| Synovial tissue inflammation in early and late osteoarthritis MJ Benito, DJ Veale, O FitzGerald, WB Van Den Berg, B Bresnihan Annals of the rheumatic diseases 64 (9), 1263-1267, 2005 | 1304 | 2005 |
| European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies: 2015 update L Gossec, JS Smolen, S Ramiro, M De Wit, M Cutolo, M Dougados, ... Annals of the rheumatic diseases 75 (3), 499-510, 2016 | 1143 | 2016 |
| Group for research and assessment of psoriasis and psoriatic arthritis 2015 treatment recommendations for psoriatic arthritis LC Coates, A Kavanaugh, PJ Mease, ER Soriano, ... Arthritis & rheumatology 68 (5), 1060-1071, 2016 | 1087 | 2016 |
| Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity LC Tsoi, SL Spain, J Knight, E Ellinghaus, PE Stuart, F Capon, J Ding, ... Nature genetics 44 (12), 1341-1348, 2012 | 1078 | 2012 |
| Genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1 A Strange, F Capon, CCA Spencer, J Knight, ME Weale, MH Allen, ... Nature genetics 42 (11), 985, 2010 | 1030 | 2010 |
| 2016 classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European League Against Rheumatism/American College of … A Ravelli, F Minoia, S Davì, AC Horne, F Bovis, A Pistorio, M Aricò, ... Arthritis & rheumatology 68 (3), 566-576, 2016 | 888 | 2016 |
| A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience D Kane, L Stafford, B Bresnihan, O FitzGerald Rheumatology 42 (12), 1460-1468, 2003 | 744 | 2003 |
| Treatment recommendations for psoriatic arthritis CT Ritchlin, A Kavanaugh, DD Gladman, PJ Mease, P Helliwell, ... Annals of the rheumatic diseases 68 (9), 1387-1394, 2009 | 739 | 2009 |
| Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force JS Smolen, M Schöls, J Braun, M Dougados, O FitzGerald, DD Gladman, ... Annals of the rheumatic diseases 77 (1), 3-17, 2018 | 722 | 2018 |
| Synovial tissue macrophage populations and articular damage in rheumatoid arthritis D Mulherin, O Fitzgerald, B Bresnihan Arthritis & Rheumatism: Official Journal of the American College of …, 1996 | 671 | 1996 |
| Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force JS Smolen, J Braun, M Dougados, P Emery, O FitzGerald, P Helliwell, ... Annals of the rheumatic diseases 73 (1), 6-16, 2014 | 618 | 2014 |
| Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis M Haroon, P Gallagher, O FitzGerald Annals of the rheumatic diseases 74 (6), 1045-1050, 2015 | 614 | 2015 |
| European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies L Gossec, JS Smolen, C Gaujoux-Viala, Z Ash, H Marzo-Ortega, ... Annals of the rheumatic diseases 71 (1), 4-12, 2012 | 608 | 2012 |
| Cytoskeletal remodelling and slow dynamics in the living cell P Bursac, G Lenormand, B Fabry, M Oliver, DA Weitz, V Viasnoff, ... Nature materials 4 (7), 557-561, 2005 | 578 | 2005 |
| Tofacitinib or adalimumab versus placebo for psoriatic arthritis P Mease, S Hall, O FitzGerald, D van der Heijde, JF Merola, ... New England Journal of Medicine 377 (16), 1537-1550, 2017 | 534 | 2017 |
| Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis U Hüffmeier, S Uebe, AB Ekici, J Bowes, E Giardina, E Korendowych, ... Nature genetics 42 (11), 996-999, 2010 | 430 | 2010 |
| Comparison of the accuracy of steroid placement with clinical outcome in patients with shoulder symptoms JA Eustace, DP Brophy, RP Gibney, B Bresnihan, O FitzGerald Annals of the rheumatic diseases 56 (1), 59-63, 1997 | 410 | 1997 |
| Inequities in access to biologic and synthetic DMARDs across 46 European countries P Putrik, S Ramiro, TK Kvien, T Sokka, M Pavlova, T Uhlig, A Boonen, ... Annals of the rheumatic diseases 73 (1), 198-206, 2014 | 382 | 2014 |
| Consensus on a core set of domains for psoriatic arthritis. DD Gladman, PJ Mease, V Strand, P Healy, PS Helliwell, O Fitzgerald, ... The Journal of rheumatology 34 (5), 1167-1170, 2007 | 350 | 2007 |
| A systematic literature review of drug therapies for the treatment of psoriatic arthritis: current evidence and meta-analysis informing the EULAR recommendations for the … Z Ash, C Gaujoux-Viala, L Gossec, EMA Hensor, O FitzGerald, K Winthrop, ... Annals of the rheumatic diseases 71 (3), 319-326, 2012 | 349 | 2012 |
